NCT02972580 Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02964377 Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents Status COMPLETED Phase PHASE1/PHASE2
NCT02958202 Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD) Status TERMINATED Phase PHASE2
NCT02907619 An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE2
NCT02891434 Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase NA
NCT02858362 Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) Status TERMINATED Phase PHASE2
NCT02851797 Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE3
NCT02819557 Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE2
NCT02780492 Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study Status COMPLETED Phase N/A
NCT02760277 An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT02760264 A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT02752048 A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE2
NCT02740972 Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT02704325 Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 Status WITHDRAWN Phase PHASE1/PHASE2
NCT02667483 Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE1/PHASE2
NCT02606136 Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Status TERMINATED Phase PHASE2
NCT02592941 Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy Status APPROVED_FOR_MARKETING Phase N/A
NCT02571205 Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy Status COMPLETED Phase N/A